Jade Biosciences, Inc. (JBIO)

Jade Biosciences Statistics

Total Valuation

JBIO has a market cap or net worth of $1.16 billion. The enterprise value is $806.07 million.

Market Cap	1.16B
Enterprise Value	806.07M

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

JBIO has 49.36 million shares outstanding.

Current Share Class	49.36M
Shares Outstanding	49.36M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+7.01%
Owned by Insiders (%)	0.36%
Owned by Institutions (%)	78.35%
Float	32.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.64
P/TBV Ratio	3.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.29, with a Debt / Equity ratio of 0.00.

Current Ratio	14.29
Quick Ratio	13.96
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-37.11

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-44.96%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.73M
Employee Count	55
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, JBIO has paid $74,000 in taxes.

Income Tax	74,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +217.39% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+217.39%
50-Day Moving Average	19.76
200-Day Moving Average	13.60
Relative Strength Index (RSI)	53.15
Average Volume (20 Days)	573,091

Short Selling Information

The latest short interest is 3.10 million, so 6.27% of the outstanding shares have been sold short.

Short Interest	3.10M
Short Previous Month	3.06M
Short % of Shares Out	6.27%
Short % of Float	9.46%
Short Ratio (days to cover)	3.98

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-133.60M
Pretax Income	-129.54M
Net Income	-95.10M
EBITDA	n/a
EBIT	-133.60M
Earnings Per Share (EPS)	-$2.11

Balance Sheet

The company has $311.30 million in cash and $849,000 in debt, with a net cash position of $310.45 million or $6.29 per share.

Cash & Cash Equivalents	311.30M
Total Debt	849,000
Net Cash	310.45M
Net Cash Per Share	$6.29
Equity (Book Value)	296.46M
Book Value Per Share	6.01
Working Capital	296.23M

Cash Flow

In the last 12 months, operating cash flow was -$100.01 million and capital expenditures -$196,000, giving a free cash flow of -$100.21 million.

Operating Cash Flow	-100.01M
Capital Expenditures	-196,000
Depreciation & Amortization	35,000
Net Borrowing	n/a
Free Cash Flow	-100.21M
FCF Per Share	-$2.03

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-8.52%
FCF Yield	-8.98%

Analyst Forecast

The average price target for JBIO is $32.86, which is 39.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.86
Price Target Difference	39.83%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a